Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...

As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...

Bar-Ilan University hosts the signing of a historic agreement with Moroccan counterparts for multidisciplinary cooperation in ...

GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...

The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in obesity, with some also earmarked for two other programmes – an ...

See which two high-touch surfaces need some extra elbow grease (and disinfectant) this winter, according to an MD.

The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Astellas' CEO said he doesn't want to make acquisitions simply to fill a revenue gap. Takeda is preparing for Trintellix's U.S. patent expiry with a round of layoffs. | Astellas CEO said he doesn't ...

Sub-Saharan Africa Pharmaceuticals Market OverviewThe Sub-Saharan Africa (SSA) pharmaceuticals market is emerging as one of the fastest-growing healthcare segments, driven by shifting disease patterns ...